BioCorRx (BICX) Payables (2016 - 2025)
Historic Payables for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to $13.9 million.
- BioCorRx's Payables rose 10012.39% to $13.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year increase of 10012.39%. This contributed to the annual value of $6.9 million for FY2024, which is 3162.49% up from last year.
- As of Q3 2025, BioCorRx's Payables stood at $13.9 million, which was up 10012.39% from $13.4 million recorded in Q2 2025.
- In the past 5 years, BioCorRx's Payables registered a high of $13.9 million during Q3 2025, and its lowest value of $2.6 million during Q2 2021.
- Moreover, its 5-year median value for Payables was $4.7 million (2023), whereas its average is $6.0 million.
- Per our database at Business Quant, BioCorRx's Payables skyrocketed by 570.26% in 2022 and then soared by 11372.68% in 2025.
- BioCorRx's Payables (Quarter) stood at $4.0 million in 2021, then increased by 5.7% to $4.2 million in 2022, then grew by 24.98% to $5.3 million in 2023, then skyrocketed by 31.62% to $6.9 million in 2024, then skyrocketed by 101.63% to $13.9 million in 2025.
- Its Payables was $13.9 million in Q3 2025, compared to $13.4 million in Q2 2025 and $12.4 million in Q1 2025.